과제정보
연구 과제 주관 기관 : 대한우울.조울병학회, 대한정신약물학회
참고문헌
- Cox JH, Seri S, Cavanna AE. Clinical guidelines on long-term pharmacotherapy for bipolar disorder in children and adolescents. J Clin Med 2014;3:135-143. https://doi.org/10.3390/jcm3010135
- National Institute for Health and Care Excellence. Bipolar disorder: The management of bipolar disorder in adults, children and adolescents, in primary and secondary care; National Institute for Health and Care Excellence: London, UK, 2006.
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. American Psychiatric; Washington, DC; 2013
- Kim DJ, Ahn YM, Kang DY, Kim SH, Kim CY, Min KJ, et al. Korean medication algorithm projects for major psychiatric disorders (II): background, basic plan, organization of KMAP and principles, methods of algorithm development and limitation, caution when sing KMAP. Korean J Psychopharmacol 2002;13:30-36.
- Bahk WM, Shin YC, Jon DI, Yoon BH, Kim DJ, Ahn YM, et al. Korean medication algorithm for bipolar disorder (I). Korean J Psychopharmacol 2002;13:205-221.
- Shin YC, Min KJ, Jon DI, Yoon BH, Bahk WM. Korean medication algorithm for bipolar disorder (II): manic episode. Korean J Psychopharmacol 2003;14:223-230.
- Min KJ, Shin YC, Jon DI, Yoon BH, Kwon JS, Bahk WM. Korean medication algorithm for bipolar disorder (III): depressive episode. Korean J Psychopharmacol 2003;14:336-346.
- Jon DI, Yoon BH, Min KJ, Shin YC, Kwon JS, Bahk WM. Korean medication algorithm for bipolar disorder (IV): rapid cycling. Korean J Psychopharmacol 2004;15:44-50.
- Yoon BH, Jon DI, Shin YC, Min KJ, Kwon JS, Bahk WM. Korean medication algorithm for bipolar disorder (V): comparisons with other treatment guidelines. Korean J Psychopharmacol 2004;15:162-174.
- Kim CH, Min KJ, Shin YC, Yun BH, Cho HS, Jon DI, et al. Feasibility of Korean medication algorithm for bipolar disorder (I): global assessment. Korean J Psychopharmacol 2005;16:225-233.
- Shin YC, Bahk WM, Kim CH, Min KJ, Yun BH, Cho HS, et al. Feasibility of korean medication algorithm for bipolar disorder (II): choice of medications. Korean J Psychopharmacol 2005;16:285-291.
- Jon DI, Bahk WM, Shin YC, Kim CH, Min KJ, Yun BH, et al. Feasibility of korean medication algorithm for bipolar disorder (III): treatment response and tolerability. Korean J Psychopharmacol 2005;16:292-300.
- Min KJ, Bahk WM, Jon DI, Shin YC, Kim CH, Yoon BH, et al. Feasibility of korean medication algorithm for bipolar disorder (IV): quality of life. Korean J Psychopharmacol 2005;16:396-405.
- Jon DI, Bahk WM, Min KJ, Shin YC, Yoon BH, Cho HS, et al. Korean medication algorithm for bipolar disorder 2006 (I). Korean J Psychopharmacol 2006;17:349-361.
- Jon DI, Bahk WM, Yoon BH, Shin YC, Cho HS, Lee E, et al. Revised korean medication algorithm for bipolar disorder. World J Biol Psychiatry 2009;10:846-855. https://doi.org/10.1080/15622970802144865
- Shin YC, Min KJ, Yoon BH, Kim W, Jon DI, Seo JS, et al. Korean medication algorithm for bipolar disorder: second revision. Asia Pac Psychiatry 2013;5:301-308. https://doi.org/10.1111/appy.12062
- Kowatch RA, Fristad M, Birmaher B, Wagner KD, Findling RL, Hellander M. Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2005;44:213-235. https://doi.org/10.1097/00004583-200503000-00006
- McClellan J, Kowatch R, Findling RL. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2007;46:107-125. https://doi.org/10.1097/01.chi.0000242240.69678.c4
- Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord 2013;15:1-44.
- Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord 2018;20:97-170. https://doi.org/10.1111/bdi.12609
- European Medicines Agency (EMA). Committee for Medicinal Products for Human Use (CHMP) Guideline on clinical investigation of medicinal products in the treatment of depression. EMA 2010.
- Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP. The expert consensus guideline series: medication treatment of bipolar disorder. J Postgrad Med 2000;1:1-104.
- Shim SH, Bahk WM, Sohn IK, Kim M-D, Lee JG, Yoon BH, et al. Korean medication algorithm for bipolar disorder 2014: children & adolescents. J of Kor Soc for Dep and Bip Disorder 2014;12:67-78.
- Geller B, Luby JL, Joshi P, Wagner KD, Emslie G, Walkup JT, et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Arch Gen Psychiatry 2012;69:515-528. https://doi.org/10.1001/archgenpsychiatry.2011.1508
- Meduri M, Gregoraci G, Baglivo V, Balestrieri M, Isola M, Brambilla P. A meta-analysis of efficacy and safety of aripiprazole in adult and pediatric bipolar disorder in randomized controlled trials and observational studies. J Afffect Disord 2016;191:187-208. https://doi.org/10.1016/j.jad.2015.11.033
- Suttajit S, Srisurapanont M, Maneeton N, Maneeton B. Quetiapine for acute bipolar depression: a systematic review and meta-analysis. Drug Des Devel Ther 2014;8:827-838.
- Schneck CD, Chang KD, Singh MK, DelBello MP, Miklowitz DJ. A pharmacologic algorithm for youth who are at high risk for bipolar disorder. J Child Adolesc Psychopharmacol 2017;27:796-805. https://doi.org/10.1089/cap.2017.0035
- Findling RL, Youngstrom EA, Rowles BM, Deyling E, Lingler J, Stansbrey RJ, et al. A double-blind and placebo-controlled trial of aripiprazole in symptomatic youths at genetic high risk for bipolar disorder. J Child Adolesc Psychopharmacol 2017;27:864-874. https://doi.org/10.1089/cap.2016.0160
- Shon SH, Joo Y, Lee JS, Kim HW. Lamotrigine treatment of adolescents with unipolar and bipolar depression: a retrospective chart review. J Child Adolesc Psychopharmacol 2014; 24: 285-287. https://doi.org/10.1089/cap.2013.0121
- Biederman J, Joshi G, Mick E, Doyle R, Georgiopoulos A, Hammerness P, et al. A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder. CNS Neurosci Ther 2010;16:91-102. https://doi.org/10.1111/j.1755-5949.2009.00121.x